Evidence map›Paper›PMID 26609812›Full record

ArticleeLife2015

ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA.

Charlotte Lässig, Sarah Matheisl, Konstantin M J Sparrer, Carina C de Oliveira Mann, Manuela Moldt, Jenish R Patel, Marion Goldeck, Gunther Hartmann, Adolfo García-Sastre, Veit Hornung and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Charlotte LässigGene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany.
Sarah MatheislGene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany.
Konstantin M J SparrerMax von Pettenkofer-Institute, Gene Center, Ludwig Maximilian University of Munich, Munich, Germany.
Carina C de Oliveira MannGene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany.
Manuela MoldtGene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany.
Jenish R PatelDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States.
Marion GoldeckInstitute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, University of Bonn, Bonn, Germany.
Gunther HartmannInstitute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, University of Bonn, Bonn, Germany.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States.
Veit HornungInstitute of Molecular Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany.
Karl-Klaus ConzelmannMax von Pettenkofer-Institute, Gene Center, Ludwig Maximilian University of Munich, Munich, Germany.
Roland BeckmannGene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany.
Karl-Peter HopfnerGene Center, Department of Biochemistry, Ludwig Maximilian University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-4528-8357
Ludwig-Maximilians-Universität München · DEUniversity of Bonn · DECenter for Integrated Protein Science Munich · DECzech Academy of Sciences, Institute of Microbiology · CZHarvard University · US

Funding

TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
NIAID NIH HHS 5T32AI007647-13NIAID NIH HHS T32 AI007647
6 · The paper itself

Abstract

The cytosolic antiviral innate immune sensor RIG-I distinguishes 5' tri- or diphosphate containing viral double-stranded (ds) RNA from self-RNA by an incompletely understood mechanism that involves ATP hydrolysis by RIG-I's RNA translocase domain. Recently discovered mutations in ATPase motifs can lead to the multi-system disorder Singleton-Merten Syndrome (SMS) and increased interferon levels, suggesting misregulated signaling by RIG-I. Here we report that SMS mutations phenocopy a mutation that allows ATP binding but prevents hydrolysis. ATPase deficient RIG-I constitutively signals through endogenous RNA and co-purifies with self-RNA even from virus infected cells. Biochemical studies and cryo-electron microscopy identify a 60S ribosomal expansion segment as a dominant self-RNA that is stably bound by ATPase deficient RIG-I. ATP hydrolysis displaces wild-type RIG-I from this self-RNA but not from 5' triphosphate dsRNA. Our results indicate that ATP-hydrolysis prevents recognition of self-RNA and suggest that SMS mutations lead to unintentional signaling through prolonged RNA binding.

Indexed as

Adenosine TriphosphateCell LineDEAD Box Protein 58DEAD-box RNA HelicasesHumansHydrolysisReceptors, ImmunologicRNA, ViralSubstrate SpecificityAdenosine TriphosphateDEAD Box Protein 58DEAD-box RNA HelicasesReceptors, ImmunologicRIGI protein, humanRNA, ViralATPase domainautoimmune response / diseasecell biologyhumanimmunologyinnate immune systemRIG-IRLRSingleton-Merten Syndrome

Identifiers

PMID26609812
PMCPMC4733034
OpenAlexW2256482451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.